We have 40 senior Life Sciences experts in our Aberdeen, Beijing, Birmingham, Dubai, Doha, Edinburgh, London, Manchester, Munich, Paris, Shanghai and Singapore offices. Our international team provides a unique offering to our Life Sciences clients; advice on all "business critical" and "business as usual" issues. Our wider team boasts 70 specialists all of whom have broad Life Sciences expertise including many with backgrounds in medicine, medicinal chemistry, pharmacology, genetics, molecular biology and biochemistry. The team also continues to grow.
As a firm we invest in understanding clients' strategic goals, their market position and attitude to risk and return. We endeavour to devise innovative solutions in response to your business needs. By working in partnership, we seek to identify what is important to you to enable us to provide tailored, business relevant advice, aligned to your broader strategic vision. We support clients through all stages of the product lifecycle - from investment for early stage R&D and technology transfer through to market entry and beyond..
We act for a range of world class clients across the life sciences industry, both public and private. Our clients include pharma, biotechs, medtechs, CROs, generic manufacturers, parallel distributors, wholesalers and pharmacists. We are the leading law firm in the UK for AIM listed Life Sciences companies and for advising the most AIM listed companies.
Our expertise and experience
The following is a summary of our expertise.
- Brand protection and reputation management
- Competition, regulatory and compliance
- Commercial & alliance transactions
- Corporate finance
- Intellectual property strategy
- Mergers and acquisitions
- Patent litigation
- Public sector
What Others Say
"Pinsent Masons offers specialist counsel to suit companies' requirements across the spectrum of the life sciences market, be it with regard to IP and patent litigation, portfolio management, regulatory or transactional work. The firm's work in the arena of patent litigation is particularly appreciated by peers and clients." Chambers 2013